A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG

Documenti analoghi

• A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG.
  di: Valentina Citro, et al.
  Pubblicazione: (2017-01-01)
• The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers
  di: Citro, Valentina, et al.
  Pubblicazione: (2018)
• β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG
  di: Maria Monticelli, et al.
  Pubblicazione: (2019-08-01)
• β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG
  di: Monticelli, Maria, et al.
  Pubblicazione: (2019)
• Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2
  di: Andreotti, Giuseppina, et al.
  Pubblicazione: (2015)